BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 6, 2026
See today's BioWorld
Home
» K-sunshine act aims to clean up corruption in S. Korean pharma sector
To read the full story,
subscribe
or
sign in
.
K-sunshine act aims to clean up corruption in S. Korean pharma sector
July 31, 2017
By
Haky Moon
HONG KONG – After the kickback scandal involving Novartis AG, South Korean authorities are determined to root out corruption from the country's pharmaceutical sector. (See BioWorld Today, Sept. 6, 2016.)
BioWorld